Investor Summary

BioClinica Stock Symbol: BIOC
Exchange: NASDAQ
SIC Number: 8071
CIK Number: 0000822418
CUSIP Number: 09071B 100
Share Data at 30 September, 2011
Authorized: 36,000,000
Outstanding: 15,662,550

Transfer Agent

Computershare Trust Company
Attention: Team A
350 Indiana Street, Suite 800
Golden, CO 80401
Phone 303-262-0888 or 1-800-962-4284
Fax 303-262-0631

Company Counsel

Morgan, Lewis & Bockius LLP
502 Carnegie Center
Princeton, New Jersey 08540

Independent Auditors

PricewaterhouseCoopers LLP
Two Commerce Square, Suite 1700
2001 Market Street
Philadelphia, Pennsylvania 19103-7042

Company Overview

BioClinica, Inc. is a global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transfer, electronic data capture, interactive voice and web response, clinical trial management, and clinical supply chain forecasting and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.

For more information, visit BioClinica's company overview page.